Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX) — Cash Flow Quality Index
Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX) has a Cash Flow Quality Index of -0.37x as of March 2026. Operating cash flow of $-28.73 Million is below net income of $78.00 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore cash flow conversion of Amneal Pharmaceuticals, Inc. Class A Com to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Amneal Pharmaceuticals, Inc. Class A Common Stock Cash Flow Quality Index (2014–2025)
Historical Cash Flow Quality Index for Amneal Pharmaceuticals, Inc. Class A Common Stock across 7 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check total reinvestment intensity of Amneal Pharmaceuticals, Inc. Class A Com to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Amneal Pharmaceuticals, Inc. Class A Common Stock (2014–2025)
Year-by-year earnings quality comparison for Amneal Pharmaceuticals, Inc. Class A Common Stock. For live market cap and the full company financial profile, see Amneal Pharmaceuticals, Inc. Class A Com (AMRX) market capitalisation.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 4.72x | $339.99 Million | $72.06 Million | ▼ -79.3% |
| 2021 | 22.76x | $241.82 Million | $10.62 Million | ▲ +446.9% |
| 2020 | 4.16x | $379.00 Million | $91.06 Million | ▲ +200.9% |
| 2017 | 1.38x | $234.19 Million | $169.32 Million | ▲ +151.7% |
| 2016 | 0.55x | $115.06 Million | $209.43 Million | ▼ -11.2% |
| 2015 | 0.62x | $104.88 Million | $169.45 Million | ▼ -2.4% |
| 2014 | 0.63x | $112.26 Million | $176.93 Million | — |